Fate Therapeutics Aktie
0,88
EUR
-0,03
EUR
-3,39
%
1,01
USD
-0,01
USD
-0,99
%
Werbung
Fate Therapeutics Aktie Analyse
| 09.08.19 | Fate Therapeutics Buy | BTIG Research | |
| 22.07.19 | Fate Therapeutics Overweight | Cantor Fitzgerald | |
| 12.07.19 | Fate Therapeutics Outperform | Oppenheimer & Co. Inc. | |
| 12.10.17 | Fate Therapeutics Buy | H.C. Wainwright & Co. | |
| 08.11.16 | Fate Therapeutics Outperform | Wedbush Morgan Securities Inc. | |
| 15.04.16 | Fate Therapeutics Outperform | BMO Capital Markets | |
| 11.05.15 | Fate Therapeutics Buy | H.C. Wainwright & Co. |
Werbung
Werbung